GlassScriptPhysician profile
Joseph Mcallister
NPI 1023014545
$8,302.33
in general payments reported to CMS, 2019-2025
35 companies · $2,486 in 2025
The $2,486 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,629 · 2020: $467 · 2021: $333 · 2022: $153 · 2023: $270 · 2024: $1,964 · 2025: $2,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,720.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,568.81 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $994.03 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $922.55 | 2019-2025 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $760.55 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $730.07 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Amgen INC. | $567.23 | 2019-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $323.32 | 2019-2024 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $222.35 | 2024-2025 | |
| Electromed, INC. | $214.01 | 2024-2025 | Smartvest |
| Boston Scientific Corporation | $187.43 | 2020-2024 | Wavewriter Alpha Prime 16, Bodyguardian |
| Intra-Sana Laboratories | $156.23 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Teva Pharmaceuticals USA, INC. | $146.48 | 2019 | |
| Astellas Pharma US INC | $118.02 | 2019-2025 | Veozah |
| Genzyme Corporation | $115.00 | 2022 | |
| Abbott Laboratories | $113.98 | 2024-2025 | Freestyle Libre 3 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mcallister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.